Émilie Narni-Mancinelli

9PUBLICATIONS
24CO-AUTHORS
Molecular targetsGenetic immunologyInnate immunityHaematological tumoursPsychophysiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 31, 2025
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

Sophie Guia, Aurore Fenis, Camille Baudesson De Chanville

|Jul 02, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneity.

Lucas Rebuffet, Janine E Melsen, Bertrand Escalière

|Feb 21, 2024
Natural killer cell therapies.

Eric Vivier, Lucas Rebuffet, Emilie Narni-Mancinelli

|Jan 25, 2024
New immune cell engagers for cancer immunotherapy.

Aurore Fenis, Olivier Demaria, Laurent Gauthier

|Aug 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.

Mathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel

|Sep 30, 2021
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia.

Adeline Crinier, Pierre-Yves Dumas, Bertrand Escalière

Pageof 2

Frequent Collaborators

7 joint publications

Éric Vivier

1 joint publications

Marco Greppi

1 joint publications

Florence Lhospice

1 joint publications

Nicolas Macagno